NFE2L2 and cancer: Zhou et al., in their bioinformatic analysis, showed that TrkB-T1 was the most abundant alternative splicing for NTRK2 mRNA in OSCC, correlating with NFE2L2, PIK3CA, and SOX2 pathways that promote the cancer progression [49].